Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,052 | 40,576 | 43,247 | 36,185 | 17,171 |
| Marketable Securities | 62,571 | 77,012 | 93,935 | 114,099 | 157,338 |
| Receivables | 3,103 | 3,352 | 2,775 | 13,177 | 3,432 |
| TOTAL | $107,305 | $124,180 | $143,080 | $167,247 | $182,936 |
| Non-Current Assets | |||||
| PPE Net | 2,467 | 2,942 | 3,316 | 3,567 | 3,958 |
| Intangibles | 1,532 | 1,569 | 1,605 | 1,642 | 1,678 |
| Other Non-Current Assets | 9,229 | 10,290 | 11,218 | 12,231 | 13,220 |
| TOTAL | $13,228 | $14,801 | $16,139 | $17,440 | $18,856 |
| Total Assets | $120,533 | $138,981 | $159,219 | $184,687 | $201,792 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,088 | 1,422 | 611 | 1,964 | 1,458 |
| Accrued Expenses | 12,338 | 16,742 | 13,620 | 14,220 | 17,599 |
| TOTAL | $85,772 | $119,228 | $142,858 | $144,536 | $155,913 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 67,201 | 96,063 | 123,766 | 123,628 | 132,267 |
| Other Non-Current Liabilities | 8,355 | 9,649 | 10,878 | 12,088 | 13,278 |
| TOTAL | $35,217 | $43,205 | $47,588 | $71,831 | $93,326 |
| Total Liabilities | $120,989 | $162,433 | $190,446 | $216,367 | $249,239 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 80,100 | 78,259 | 78,118 | 77,919 | 67,722 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -691,579 | -710,455 | -716,191 | -709,657 | -723,448 |
| Other shareholders' equity | 27 | 40 | -4 | -10 | 95 |
| TOTAL | $-456 | $-23,452 | $-31,227 | $-31,680 | $-47,447 |
| Total Liabilities And Equity | $120,533 | $138,981 | $159,219 | $184,687 | $201,792 |